Matching samples

Patient A01, IBS, Baseline Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1632703
sample_title: Patient A01, IBS, Baseline Before Intervention
source_name: Peripheral blood
characteristics: patient: A01; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood

Patient A01, IBS, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. Case: organism: Homo sapiens — Insufficient evidence. Case: assay type: bulk RNA-seq — Insufficient evidence. Case: specimen category: Tissue or biopsy — Insufficient evidence. Control: organism: Homo sapiens — Insufficient evidence. Control: assay type: bulk RNA-seq — Insufficient evidence. Control: specimen category: Tissue or biopsy — Insufficient evidence. Study role: No explicit case or control marker detected.

sample_accession: GSM1632704
sample_title: Patient A01, IBS, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: A01; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient A02, IBS, Baseline Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1632705
sample_title: Patient A02, IBS, Baseline Before Intervention
source_name: Peripheral blood
characteristics: patient: A02; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood

Patient A02, IBS, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. Case: organism: Homo sapiens — Insufficient evidence. Case: assay type: bulk RNA-seq — Insufficient evidence. Case: specimen category: Tissue or biopsy — Insufficient evidence. Control: organism: Homo sapiens — Insufficient evidence. Control: assay type: bulk RNA-seq — Insufficient evidence. Control: specimen category: Tissue or biopsy — Insufficient evidence. Study role: No explicit case or control marker detected.

sample_accession: GSM1632706
sample_title: Patient A02, IBS, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: A02; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient A03, IBS, Baseline Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1632707
sample_title: Patient A03, IBS, Baseline Before Intervention
source_name: Peripheral blood
characteristics: patient: A03; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood

Patient A03, IBS, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. Case: organism: Homo sapiens — Insufficient evidence. Case: assay type: bulk RNA-seq — Insufficient evidence. Case: specimen category: Tissue or biopsy — Insufficient evidence. Control: organism: Homo sapiens — Insufficient evidence. Control: assay type: bulk RNA-seq — Insufficient evidence. Control: specimen category: Tissue or biopsy — Insufficient evidence. Study role: No explicit case or control marker detected.

sample_accession: GSM1632708
sample_title: Patient A03, IBS, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: A03; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient A06, IBS, Baseline Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1632709
sample_title: Patient A06, IBS, Baseline Before Intervention
source_name: Peripheral blood
characteristics: patient: A06; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood

Patient A06, IBS, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. Case: organism: Homo sapiens — Insufficient evidence. Case: assay type: bulk RNA-seq — Insufficient evidence. Case: specimen category: Tissue or biopsy — Insufficient evidence. Control: organism: Homo sapiens — Insufficient evidence. Control: assay type: bulk RNA-seq — Insufficient evidence. Control: specimen category: Tissue or biopsy — Insufficient evidence. Study role: No explicit case or control marker detected.

sample_accession: GSM1632710
sample_title: Patient A06, IBS, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: A06; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient A07, IBS, Baseline Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1632711
sample_title: Patient A07, IBS, Baseline Before Intervention
source_name: Peripheral blood
characteristics: patient: A07; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood

Patient A07, IBS, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. Case: organism: Homo sapiens — Insufficient evidence. Case: assay type: bulk RNA-seq — Insufficient evidence. Case: specimen category: Tissue or biopsy — Insufficient evidence. Control: organism: Homo sapiens — Insufficient evidence. Control: assay type: bulk RNA-seq — Insufficient evidence. Control: specimen category: Tissue or biopsy — Insufficient evidence. Study role: No explicit case or control marker detected.

sample_accession: GSM1632712
sample_title: Patient A07, IBS, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: A07; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient A10, IBS, Baseline Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1632713
sample_title: Patient A10, IBS, Baseline Before Intervention
source_name: Peripheral blood
characteristics: patient: A10; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood

Patient A10, IBS, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. Case: organism: Homo sapiens — Insufficient evidence. Case: assay type: bulk RNA-seq — Insufficient evidence. Case: specimen category: Tissue or biopsy — Insufficient evidence. Control: organism: Homo sapiens — Insufficient evidence. Control: assay type: bulk RNA-seq — Insufficient evidence. Control: specimen category: Tissue or biopsy — Insufficient evidence. Study role: No explicit case or control marker detected.

sample_accession: GSM1632714
sample_title: Patient A10, IBS, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: A10; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient A13, IBS, Baseline Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1632715
sample_title: Patient A13, IBS, Baseline Before Intervention
source_name: Peripheral blood
characteristics: patient: A13; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood

Patient A13, IBS, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. Case: organism: Homo sapiens — Insufficient evidence. Case: assay type: bulk RNA-seq — Insufficient evidence. Case: specimen category: Tissue or biopsy — Insufficient evidence. Control: organism: Homo sapiens — Insufficient evidence. Control: assay type: bulk RNA-seq — Insufficient evidence. Control: specimen category: Tissue or biopsy — Insufficient evidence. Study role: No explicit case or control marker detected.

sample_accession: GSM1632716
sample_title: Patient A13, IBS, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: A13; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient A14, IBS, Baseline Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1632717
sample_title: Patient A14, IBS, Baseline Before Intervention
source_name: Peripheral blood
characteristics: patient: A14; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood

Patient A14, IBS, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. Case: organism: Homo sapiens — Insufficient evidence. Case: assay type: bulk RNA-seq — Insufficient evidence. Case: specimen category: Tissue or biopsy — Insufficient evidence. Control: organism: Homo sapiens — Insufficient evidence. Control: assay type: bulk RNA-seq — Insufficient evidence. Control: specimen category: Tissue or biopsy — Insufficient evidence. Study role: No explicit case or control marker detected.

sample_accession: GSM1632718
sample_title: Patient A14, IBS, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: A14; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient A15, IBS, Baseline Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1632719
sample_title: Patient A15, IBS, Baseline Before Intervention
source_name: Peripheral blood
characteristics: patient: A15; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood

Patient A15, IBS, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. Case: organism: Homo sapiens — Insufficient evidence. Case: assay type: bulk RNA-seq — Insufficient evidence. Case: specimen category: Tissue or biopsy — Insufficient evidence. Control: organism: Homo sapiens — Insufficient evidence. Control: assay type: bulk RNA-seq — Insufficient evidence. Control: specimen category: Tissue or biopsy — Insufficient evidence. Study role: No explicit case or control marker detected.

sample_accession: GSM1632720
sample_title: Patient A15, IBS, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: A15; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient A16, IBS, Baseline Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1632721
sample_title: Patient A16, IBS, Baseline Before Intervention
source_name: Peripheral blood
characteristics: patient: A16; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood

Patient A16, IBS, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. Case: organism: Homo sapiens — Insufficient evidence. Case: assay type: bulk RNA-seq — Insufficient evidence. Case: specimen category: Tissue or biopsy — Insufficient evidence. Control: organism: Homo sapiens — Insufficient evidence. Control: assay type: bulk RNA-seq — Insufficient evidence. Control: specimen category: Tissue or biopsy — Insufficient evidence. Study role: No explicit case or control marker detected.

sample_accession: GSM1632722
sample_title: Patient A16, IBS, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: A16; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient A18, IBS, Baseline Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1632723
sample_title: Patient A18, IBS, Baseline Before Intervention
source_name: Peripheral blood
characteristics: patient: A18; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood

Patient A18, IBS, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. Case: organism: Homo sapiens — Insufficient evidence. Case: assay type: bulk RNA-seq — Insufficient evidence. Case: specimen category: Tissue or biopsy — Insufficient evidence. Control: organism: Homo sapiens — Insufficient evidence. Control: assay type: bulk RNA-seq — Insufficient evidence. Control: specimen category: Tissue or biopsy — Insufficient evidence. Study role: No explicit case or control marker detected.

sample_accession: GSM1632724
sample_title: Patient A18, IBS, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: A18; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient A20, IBS, Baseline Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1632725
sample_title: Patient A20, IBS, Baseline Before Intervention
source_name: Peripheral blood
characteristics: patient: A20; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood

Patient A20, IBS, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. Case: organism: Homo sapiens — Insufficient evidence. Case: assay type: bulk RNA-seq — Insufficient evidence. Case: specimen category: Tissue or biopsy — Insufficient evidence. Control: organism: Homo sapiens — Insufficient evidence. Control: assay type: bulk RNA-seq — Insufficient evidence. Control: specimen category: Tissue or biopsy — Insufficient evidence. Study role: No explicit case or control marker detected.

sample_accession: GSM1632726
sample_title: Patient A20, IBS, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: A20; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient A23, IBS, Baseline Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1632727
sample_title: Patient A23, IBS, Baseline Before Intervention
source_name: Peripheral blood
characteristics: patient: A23; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood

Patient A23, IBS, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. Case: organism: Homo sapiens — Insufficient evidence. Case: assay type: bulk RNA-seq — Insufficient evidence. Case: specimen category: Tissue or biopsy — Insufficient evidence. Control: organism: Homo sapiens — Insufficient evidence. Control: assay type: bulk RNA-seq — Insufficient evidence. Control: specimen category: Tissue or biopsy — Insufficient evidence. Study role: No explicit case or control marker detected.

sample_accession: GSM1632728
sample_title: Patient A23, IBS, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: A23; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient A25, IBS, Baseline Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Treatment control marker detected.

sample_accession: GSM1632729
sample_title: Patient A25, IBS, Baseline Before Intervention
source_name: Peripheral blood
characteristics: patient: A25; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood; disease state: IBS; time point: baseline before intervention; tissue: peripheral blood

Patient A25, IBS, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. Case: organism: Homo sapiens — Insufficient evidence. Case: assay type: bulk RNA-seq — Insufficient evidence. Case: specimen category: Tissue or biopsy — Insufficient evidence. Control: organism: Homo sapiens — Insufficient evidence. Control: assay type: bulk RNA-seq — Insufficient evidence. Control: specimen category: Tissue or biopsy — Insufficient evidence. Study role: No explicit case or control marker detected.

sample_accession: GSM1632730
sample_title: Patient A25, IBS, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: A25; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBS; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient B01, IBD, Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632731
sample_title: Patient B01, IBD, Before Intervention
source_name: Peripheral blood
characteristics: patient: B01; disease state: IBD; time point: before intervention; tissue: peripheral blood; disease state: IBD; time point: before intervention; tissue: peripheral blood

Patient B01, IBD, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632732
sample_title: Patient B01, IBD, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: B01; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient B03, IBD, Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632733
sample_title: Patient B03, IBD, Before Intervention
source_name: Peripheral blood
characteristics: patient: B03; disease state: IBD; time point: before intervention; tissue: peripheral blood; disease state: IBD; time point: before intervention; tissue: peripheral blood

Patient B03, IBD, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632734
sample_title: Patient B03, IBD, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: B03; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient B04, IBD, Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632735
sample_title: Patient B04, IBD, Before Intervention
source_name: Peripheral blood
characteristics: patient: B04; disease state: IBD; time point: before intervention; tissue: peripheral blood; disease state: IBD; time point: before intervention; tissue: peripheral blood

Patient B04, IBD, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632736
sample_title: Patient B04, IBD, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: B04; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient B06, IBD, Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632737
sample_title: Patient B06, IBD, Before Intervention
source_name: Peripheral blood
characteristics: patient: B06; disease state: IBD; time point: before intervention; tissue: peripheral blood; disease state: IBD; time point: before intervention; tissue: peripheral blood

Patient B06, IBD, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632738
sample_title: Patient B06, IBD, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: B06; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient B07, IBD, Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632739
sample_title: Patient B07, IBD, Before Intervention
source_name: Peripheral blood
characteristics: patient: B07; disease state: IBD; time point: before intervention; tissue: peripheral blood; disease state: IBD; time point: before intervention; tissue: peripheral blood

Patient B07, IBD, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632740
sample_title: Patient B07, IBD, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: B07; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient B08, IBD, Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632741
sample_title: Patient B08, IBD, Before Intervention
source_name: Peripheral blood
characteristics: patient: B08; disease state: IBD; time point: before intervention; tissue: peripheral blood; disease state: IBD; time point: before intervention; tissue: peripheral blood

Patient B08, IBD, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632742
sample_title: Patient B08, IBD, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: B08; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient B09, IBD, Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632743
sample_title: Patient B09, IBD, Before Intervention
source_name: Peripheral blood
characteristics: patient: B09; disease state: IBD; time point: before intervention; tissue: peripheral blood; disease state: IBD; time point: before intervention; tissue: peripheral blood

Patient B09, IBD, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632744
sample_title: Patient B09, IBD, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: B09; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient B11, IBD, Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632745
sample_title: Patient B11, IBD, Before Intervention
source_name: Peripheral blood
characteristics: patient: B11; disease state: IBD; time point: before intervention; tissue: peripheral blood; disease state: IBD; time point: before intervention; tissue: peripheral blood

Patient B11, IBD, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632746
sample_title: Patient B11, IBD, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: B11; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient B12, IBD, Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632747
sample_title: Patient B12, IBD, Before Intervention
source_name: Peripheral blood
characteristics: patient: B12; disease state: IBD; time point: before intervention; tissue: peripheral blood; disease state: IBD; time point: before intervention; tissue: peripheral blood

Patient B12, IBD, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632748
sample_title: Patient B12, IBD, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: B12; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient B13, IBD, Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632749
sample_title: Patient B13, IBD, Before Intervention
source_name: Peripheral blood
characteristics: patient: B13; disease state: IBD; time point: before intervention; tissue: peripheral blood; disease state: IBD; time point: before intervention; tissue: peripheral blood

Patient B13, IBD, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632750
sample_title: Patient B13, IBD, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: B13; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient B14, IBD, Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632751
sample_title: Patient B14, IBD, Before Intervention
source_name: Peripheral blood
characteristics: patient: B14; disease state: IBD; time point: before intervention; tissue: peripheral blood; disease state: IBD; time point: before intervention; tissue: peripheral blood

Patient B14, IBD, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632752
sample_title: Patient B14, IBD, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: B14; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient B16, IBD, Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632753
sample_title: Patient B16, IBD, Before Intervention
source_name: Peripheral blood
characteristics: patient: B16; disease state: IBD; time point: before intervention; tissue: peripheral blood; disease state: IBD; time point: before intervention; tissue: peripheral blood

Patient B16, IBD, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632754
sample_title: Patient B16, IBD, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: B16; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient B20, IBD, Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632755
sample_title: Patient B20, IBD, Before Intervention
source_name: Peripheral blood
characteristics: patient: B20; disease state: IBD; time point: before intervention; tissue: peripheral blood; disease state: IBD; time point: before intervention; tissue: peripheral blood

Patient B20, IBD, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632756
sample_title: Patient B20, IBD, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: B20; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient B22, IBD, Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632757
sample_title: Patient B22, IBD, Before Intervention
source_name: Peripheral blood
characteristics: patient: B22; disease state: IBD; time point: before intervention; tissue: peripheral blood; disease state: IBD; time point: before intervention; tissue: peripheral blood

Patient B22, IBD, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632758
sample_title: Patient B22, IBD, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: B22; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient B23, IBD, Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632759
sample_title: Patient B23, IBD, Before Intervention
source_name: Peripheral blood
characteristics: patient: B23; disease state: IBD; time point: before intervention; tissue: peripheral blood; disease state: IBD; time point: before intervention; tissue: peripheral blood

Patient B23, IBD, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632760
sample_title: Patient B23, IBD, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: B23; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient B24, IBD, Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632761
sample_title: Patient B24, IBD, Before Intervention
source_name: Peripheral blood
characteristics: patient: B24; disease state: IBD; time point: before intervention; tissue: peripheral blood; disease state: IBD; time point: before intervention; tissue: peripheral blood

Patient B24, IBD, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632762
sample_title: Patient B24, IBD, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: B24; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient B25, IBD, Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632763
sample_title: Patient B25, IBD, Before Intervention
source_name: Peripheral blood
characteristics: patient: B25; disease state: IBD; time point: before intervention; tissue: peripheral blood; disease state: IBD; time point: before intervention; tissue: peripheral blood

Patient B25, IBD, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632764
sample_title: Patient B25, IBD, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: B25; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient B29, IBD, Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632765
sample_title: Patient B29, IBD, Before Intervention
source_name: Peripheral blood
characteristics: patient: B29; disease state: IBD; time point: before intervention; tissue: peripheral blood; disease state: IBD; time point: before intervention; tissue: peripheral blood

Patient B29, IBD, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632766
sample_title: Patient B29, IBD, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: B29; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood

Patient B30, IBD, Before Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632767
sample_title: Patient B30, IBD, Before Intervention
source_name: Peripheral blood
characteristics: patient: B30; disease state: IBD; time point: before intervention; tissue: peripheral blood; disease state: IBD; time point: before intervention; tissue: peripheral blood

Patient B30, IBD, After 9 weeks of Intervention

Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.

sample_accession: GSM1632768
sample_title: Patient B30, IBD, After 9 weeks of Intervention
source_name: Peripheral blood
characteristics: patient: B30; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood; disease state: IBD; time point: after 9 weeks of intervention; tissue: peripheral blood